Hydroxycarboxylic Acid Receptor 2 (HCAR2) Antibody

Este producto es parte de HCAR - Hydroxy-Carboxylic Acid Receptor
Product Graph
351€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Hydroxycarboxylic Acid Receptor 2 (HCAR2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx376195
tested applications
ELISA, WB

Description

Hydroxycarboxylic Acid Receptor 2 (HCAR2) Antibody is a Rabbit Polyclonal antibody against Hydroxycarboxylic Acid Receptor 2 (HCAR2).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Hydroxycarboxylic Acid Receptor 2 (HCAR2)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Purification
Purified by affinity chromatography using epitope-specific immunogen.
Size 1
100 µg
Form
Liquid
Tested Applications
ELISA, WB
Buffer
PBS, pH 7.4, containing 0.02% sodium azide and 50% glycerol.
Availability
Shipped within 5-12 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q8TDS4
Gene ID
338442
OMIM
609163
Alias
HCAR2,PUMAG,G-protein coupled receptor HM74A,Nicotinic acid receptor,Nic1,G protein-coupled receptor 109A,Niacr1,niacin receptor 1,HCA2,HM74a,HM74b,NIACR1,Puma-g,GPR109A
Background
Antibody anti-HCAR2
Status
RUO
Note
Concentration: 1 mg/ml -

Descripción

HCAR2, also known as GPR109A, is a G protein-coupled receptor activated by nicotinic acid (niacin) and endogenous metabolites such as β-hydroxybutyrate (BHB). It is highly expressed in adipose tissue, immune cells, and the gut, where it plays a pivotal role in lipid metabolism, inflammation, and energy homeostasis. In adipocytes, HCAR2 activation inhibits cAMP production via Gi/o proteins, leading to the suppression of lipolysis and reduced free fatty acid release, which lowers circulating triglyceride levels. HCAR2 also mediates anti-inflammatory effects in immune cells, particularly in macrophages, by inhibiting pro-inflammatory cytokine production and promoting anti-inflammatory pathways, making it a key target in atherosclerosis and inflammatory diseases. HCAR2 is activated during fasting or ketogenic states through β-hydroxybutyrate, linking it to metabolic adaptations and energy conservation. Dysregulation of HCAR2 is implicated in metabolic disorders, cardiovascular disease, and neuroinflammation. Niacin-based therapies targeting HCAR2 are used to improve lipid profiles and manage dyslipidemia, highlighting its clinical relevance.

Related Products

abx214866

Hydroxycarboxylic Acid Receptor 2 (HCAR2) Antibody

HCAR2 Antibody is a Rabbit Polyclonal against HCAR2.

Ver Producto
abx214867

Hydroxycarboxylic Acid Receptor 2 (HCAR2) Antibody

HCAR2 Antibody is a Rabbit Polyclonal against HCAR2.

Ver Producto
abx376195

Hydroxycarboxylic Acid Receptor 2 (HCAR2) Antibody

Hydroxycarboxylic Acid Receptor 2 (HCAR2) Antibody is a Rabbit Polyclonal antibody against Hydroxycarboxylic Acid Receptor 2 (HCAR2).

Ver Producto